Price T Rowe Associates Inc Novartis Ag Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Novartis Ag stock. As of the latest transaction made, Price T Rowe Associates Inc holds 120,721 shares of NVS stock, worth $12.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

120,721

Previous 7,087 1603.41%

Holding current value

$12.5 Million

Previous $755,000 1739.34%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$106.13 - $120.89 $12.1 Million - $13.7 Million	113,634 Added 1603.41%	120,721 $13.9 Million
Q2 2024 Aug 14, 2024	SELL	$92.57 - $107.37 $10.1 Million - $11.7 Million	-108,762 Reduced 93.88%	7,087 $755,000
Q1 2024 May 15, 2024	BUY	$95.27 - $108.47 $352,117 - $400,905	3,696 Added 3.3%	115,849 $11.2 Million
Q4 2023 Feb 14, 2024	SELL	$92.27 - $101.54 $116,352 - $128,041	-1,261 Reduced 1.11%	112,153 $11.3 Million
Q3 2023 Nov 14, 2023	BUY	$94.73 - $105.13 $638,290 - $708,365	6,738 Added 6.32%	113,414 $11.6 Million
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $848,778 - $962,444	9,174 Added 9.41%	106,676 $10.8 Million
Q1 2023 May 15, 2023	BUY	$80.03 - $92.81 $293,950 - $340,891	3,673 Added 3.91%	97,502 $8.97 Million
Q4 2022 Feb 14, 2023	SELL	$75.55 - $92.52 $58,475 - $71,610	-774 Reduced 0.82%	93,829 $8.51 Million
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $3.97 Million - $4.64 Million	53,220 Added 128.6%	94,603 $13.3 Million
Q2 2022 Aug 15, 2022	BUY	$80.52 - $93.75 $151,458 - $176,343	1,881 Added 4.76%	41,383 $3.5 Million
Q1 2022 May 16, 2022	BUY	$80.11 - $90.62 $424,022 - $479,651	5,293 Added 15.47%	39,502 $3.47 Million
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $70,933 - $78,435	890 Added 2.67%	34,209 $2.99 Million
Q3 2021 Nov 15, 2021	BUY	$81.78 - $95.14 $220,069 - $256,021	2,691 Added 8.79%	33,319 $2.72 Million
Q2 2021 Aug 16, 2021	BUY	$85.24 - $94.15 $261,090 - $288,381	3,063 Added 11.11%	30,628 $2.79 Million
Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $56,028 - $66,073	-671 Reduced 2.38%	27,565 $2.36 Million
Q4 2020 Feb 16, 2021	BUY	$78.07 - $94.43 $2.2 Million - $2.67 Million	28,236 New	28,236 $2.08 Million

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Novartis Ag Transaction History